Literature DB >> 28120482

Abnormal peritoneal regulation of chemokine activation-The role of IL-8 in pathogenesis of endometriosis.

Justyna Sikora1, Marta Smycz-Kubańska1, Aleksandra Mielczarek-Palacz1, Zdzisława Kondera-Anasz1.   

Abstract

PROBLEM: Endometriosis is a chronic inflammatory disease associated with an impairment in immune response. Disorders in the peritoneal fluid and ectopic endometrium macrophage populations and their secretory products create a specific microenvironment inducing the development of the disease. The important factors involved in inflammation associated with endometriosis are chemokines, especially interleukin (IL)-8. For this reason, the current study briefly reviews the role of IL-8 in the pathogenesis of endometriosis. METHOD OF STUDY: A systematic review was done on all published studies that compared IL-8 expression and concentration in patients with and without endometriosis to evaluate their potential as biomarkers for the disease.
RESULTS: IL-8 induces chemotaxis of neutrophils and other immune cells; also, it is a potent angiogenic agent. Most researchers pointed to the increased peritoneal and serum IL-8 levels and showed correlation with the severity of the disease, size and number of the active lesions. IL-8 takes part in all processes during the development of the disease: adhesion, invasion, and implantation of ectopic tissue. Additionally, the chemokine plays a role in growth and maintenance of ectopic endometrial tissue directly affecting endometrial cell proliferation. IL-8 might also protect ectopic cells against death by apoptosis.
CONCLUSION: It may act as an autocrine growth factor in the endometrium and promotes the vicious circle of endometrial cell attachment and, in consequence, may lead to a transformation from acute to chronic inflammation stage.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endometriosis; interleukin-8; peritoneal fluid; serum

Mesh:

Substances:

Year:  2017        PMID: 28120482     DOI: 10.1111/aji.12622

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  22 in total

1.  Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Authors:  Junyan Zhu; Doris Mayr; Christina Kuhn; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Histochem Cell Biol       Date:  2017-11-13       Impact factor: 4.304

2.  A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations.

Authors:  Negin Mirzaei; Shahideh Jahanian Sadatmahalleh; Safoura Rouholamin; Malihe Nasiri
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 3.  Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis.

Authors:  Jiaxing He; Weiqin Chang; Chunyang Feng; Manhua Cui; Tianmin Xu
Journal:  Int J Genomics       Date:  2018-03-27       Impact factor: 2.326

4.  Does the Use of the "Proseek® Multiplex Oncology I Panel" on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis?

Authors:  Alexandra Perricos; René Wenzl; Heinrich Husslein; Thomas Eiwegger; Manuela Gstoettner; Andreas Weinhaeusel; Gabriel Beikircher; Lorenz Kuessel
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

5.  Identification of mRNAs related to endometrium function regulated by lncRNA CD36-005 in rat endometrial stromal cells.

Authors:  Xueying Zhang; Ying Xu; Lulu Fu; Dandan Li; Xiaowei Dai; Lianlian Liu; Jingshun Zhang; Lianwen Zheng; Manhua Cui
Journal:  Reprod Biol Endocrinol       Date:  2018-10-15       Impact factor: 5.211

6.  Serum concentrations of CCL20/MIP-3alpha in women with endometriosis.

Authors:  Grzegorz Jabłoński; Bogna Sobkiewicz; Marcin Kaczmarek; Adrian Krygier; Jan Bieńkiewicz; Andrzej Malinowski
Journal:  Prz Menopauzalny       Date:  2019-04-09

Review 7.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

8.  Network Pharmacology-Based Prediction of Bioactive Compounds and Potential Targets of Wenjing Decoction for Treatment of Endometriosis.

Authors:  Yu-Nan Liu; Xiao-Jing Hu; Bei Liu; Yu-Jie Shang; Wen-Ting Xu; Hui-Fang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

9.  Inflammatory cytokine profile of co‑cultivated primary cells from the endometrium of women with and without endometriosis.

Authors:  Adriana Luckow Invitti; Eduardo Schor; Rafael Martins Parreira; Alexander Kopelman; Gil Kamergorodsky; Giovana Aparecida Gonçalves; Manoel João Batista Castello Girão
Journal:  Mol Med Rep       Date:  2018-06-06       Impact factor: 2.952

Review 10.  Curcumin and Endometriosis.

Authors:  Alexandre Vallée; Yves Lecarpentier
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.